Scancell Holdings Share Price | |
---|---|
Price | 9.875 |
Bid | 9.50 |
Ask | 10.25 |
Change | 0.175 (1.80%) |
Volume | 214,593 |
Open | 9.875 |
High | 9.875 |
Low | 9.875 |
Prev. Close | 9.70 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 928.98m |
Market Capitalisation | £91.74m |
Market Size | 30,000 |
52 Week High | 17.375 |
52 Week High Date | 20-Sep-2023 |
52 Week Low | 7.65 |
52 Week Low Date | 05-Sep-2023 |
# Trades | 7 |
---|---|
Vol. Sold | 100,000 |
Sold Value | £9.65k |
Vol. Bought | 114,593 |
Bought Value | £11.64k |
PE Ratio | -6.585968 |
Earnings | -1.4994 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
10-May-24 | 11:20:34 | 10.19 | 2,944 | Buy* | 9.50 | 10.25 | 299.99 | O Ordinary |
10-May-24 | 11:02:27 | 10.19 | 981 | Buy* | 9.50 | 10.25 | 99.96 | O Ordinary |
10-May-24 | 09:16:12 | 10.19 | 4,121 | Buy* | 9.50 | 10.25 | 419.93 | O Ordinary |
10-May-24 | 09:12:01 | 9.65 | 100,000 | Sell* | 9.50 | 10.25 | 9,650 | O Ordinary |
10-May-24 | 08:38:31 | 10.19 | 54,408 | Buy* | 9.50 | 10.25 | 5,544 | O Ordinary |
10-May-24 | 08:37:27 | 10.125 | 51,839 | Buy* | 9.50 | 10.25 | 5,249 | O Ordinary |
10-May-24 | 08:02:03 | 10.125 | 300 | Buy* | 9.50 | 10.25 | 30.38 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
06-Dec-23 | 05-Dec-23 | Buy | Lindy Durrant held the position of CEO at the time of this trade.Lindy Durrant | 11.00 | GBX | 272,727 | 272,727 |
06-Dec-23 | 05-Dec-23 | Buy | Jean-Michel Cosséry held the position of Non-Executive Chairman at the time of this trade.Jean-Michel Cosséry | 11.00 | GBX | 454,545 | 454,545 |
03-Mar-22 | 02-Mar-22 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 12.00 | GBX | 250,000 | 117,729,029 |
03-Nov-21 | 02-Nov-21 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 19.00 | GBX | 200,000 | 118,479,029 |
02-Nov-21 | 29-Oct-21 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 19.00 | GBX | 100,000 | 118,279,029 |
Scancell is focused on developing innovative immunotherapies for cancer that stimulate the body’s own immune system.